baber/WOPTO huggingface dataset:
Patent JP-H0360677-B2 (JP)
IPC: B41J21/00
Filed: 1988-01-14
Abstract: PURPOSE:To cope well with diversification of commodity and service for client, by providing a print paper feeding means, a line space modifying means, a means for converting the number of lines and a means for classifying printing items into printing item and non-printing item thereby selecting a required printing format. CONSTITUTION:Upon weighting of a third commodity, unit price, weight, price, etc., of the third commodity are printed onto a receipt then the receipt 1 is fed by one line. Upon completion of weighing of the commodity for a single client, a total print switch S3 is turned ON. Consequently, R/S flipflop 13 is set, and Q output signal (i) thereof is brought to H, thereby signals corresponding to the total price and number outputted from an adding section 5 and a character 'total' are inputted through an AND gate 16 and an OR gate 15 to a print control section 6. When the number of commodity is one and printing of total number is not required, or non-printing is executed, a paper feed switch S4 is turned ON in place of the total printing switch S3, and the total price is not printed, then the receipt is fed to cutting position and the total price is cleared.
Patent JP-3513348-B2 (JP)
IPC: H04M3/50
Filed: 1997-01-17
Granted: 2004-03-31
Abstract: A multi-media messaging system (106) provides multi-media message access capability to non-subscriber message recipients (126) who lack multi-media message-reception capability. When a message originator (100) who is a subscriber requests a message to be sent to a recipient's address, the messaging system determines whether the recipient is able to receive at this address all of the media in which the message is expressed. If not, the messaging system saves the message for the recipient, assigns an identifier/password to the message, and creates a substitute message containing any components of the original message that are expressed in media which the recipient is able to receive at the address, along with the password and instructions on how to log into the sending messaging system. The messaging system then sends this substitute message to the recipient's address. When the recipient follows the instructions and logs into the sending messaging system with the password, the messaging system allows the recipient to access only the original message. Following this access, or if the access is not made within a predetermined time period, the messaging system deletes the original message. <IMAGE>
Patent AU-729496-B2 (AU)
Title: Robo: a novel family of polypeptides and nucleic acids
Inventor: GOODMAN COREY S
IPC: A61P25/00
Filed: 1998-10-20
Granted: 2001-02-01
Abstract: Robo1 and Robo2 polypeptides may be produced recombinantly from transformed host cells from the disclosed Robo encoding nucleic acids or purified from human cells. The invention provides isolated Robo hybridization probes and primers capable of specifically hybridizing with the disclosed Robo genes, Robo-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
Patent AU-748226-B2 (AU)
Title: Method and apparatus for making arrays
Inventor: KOWALLIS REID B
IPC: C40B60/14
Filed: 1998-10-30
Granted: 2002-05-30
Abstract: Apparatus for producing a plurality of arrays of reagent regions is disclosed. A dispensing assembly in the apparatus has a plurality of heads which are spaced for depositing reagents at selected positions in different array areas in a substrate. As the heads in the assembly are advanced along array area, the regions in a row in that array are successively filled, allowing parallel deposition in several array areas at reagent regions which are closely spaced relative to the spacing between deposition heads in the assembly. Also disclosed is a method for producing a plurality of arrays using the apparatus.
Patent AU-699014-B2 (AU)
Title: Method and apparatus for ejection of particulate material
Inventor: NEWCOMBE GUY CHARLES FERNLEY
IPC: B41J2/06
Filed: 1997-01-22
Granted: 1998-11-19
Abstract: PCT No. PCT/GB97/00187 Sec. 371 Date Jul. 17, 1998 Sec. 102(e) Date Jul. 17, 1998 PCT Filed Jan. 22, 1997 PCT Pub. No. WO97/27057 PCT Pub. Date Jul. 31, 1997The invention concerns an apparatus for generation and ejection into air of discrete agglomerations of a particulate material with a proportion of liquid from a liquid having the particulate material therein. The apparatus defines an ejection location (128) and an electrical potential is applied to the ejection location to form an electric field at the location, and liquid (122) with the particulate material is supplied to the ejection location. An oscillating voltage (A) is applied to the ejection location, the magnitude of the voltage being below that required to cause ejection of particles from the ejection location, and an ejection voltage (B) is superimposed on the oscillating voltage additively with the oscillating voltage in order to cause the sum of the voltages at the ejection location to exceed the threshold required for ejection, when required.
Patent AU-609118-B2 (AU)
Title: New synthetic bioactive compounds and method of producing bioactive effect
Inventor: ZASLOFF MICHAEL ALAN
IPC: A61P31/00
Filed: 1988-02-23
Granted: 1991-04-26
Abstract: The present invention relates to a method of producing antimicrobial effect by contacting a subject susceptible to microbial invasion or contamination, with antimicrobial amount of XPF and PGLa polypeptides.
Patent AU-652043-B2 (AU)
Title: Blood coagulation factor X1 concentrate having high specific activity, suitable for therapeutic use, and process for preparing same
Inventor: BURNOUF MIRYANA
IPC: A61K38/00
Filed: 1992-04-29
Granted: 1994-08-11
Abstract: The invention relates to a human Factor XI concentrate having high specific activity prepared using a process comprising a filtration-adsorption step and a single step of chromatography on cation exchange resin. The concentrate obtained is perfectly suitable for therapeutic use in replacement therapy in cases of Factor XI deficiency.
Patent AU-770963-B2 (AU)
Title: New oligomeric conjugates liable to transfer biological molecules into cells
Inventor: MIDOUX PATRICK
IPC: A61K47/48
Filed: 1999-11-22
Granted: 2004-03-11
Abstract: The invention relates to a positively charged oligomeric conjugate, containing an oligomer with a polymerization degree (PD) from 5 to 50, preferably 10 to 40 and more preferably 20, formed from monomeric components having free NH3<+> in a number equal to or higher than 50 % of the polymerization degree. In particular, the invention provides new oligomeric conjugates of histidylated oligolysine liable to allow the transfer of oligonucleotides, peptides and oligosides into cells.
Patent AU-653811-B2 (AU)
Title: Speaker recognition method
Inventor: VANSKA MARKO
IPC: G10L15/02
Filed: 1992-04-29
Granted: 1994-10-13
Abstract: The invention relates to a speaker recognition method, comprising comparing a model calculated on the basis of samples derived from a speech signal with a stored model of at least one known speaker. In the method according to the invention, the averages of the cross-sectional areas or other cross-sectional dimensions of portions (C1 - C8) of a lossless tube model of the speaker's vocal tract, calculated by means of the samples derived from the speech signal, are compared with the corresponding averages of the portions of the stored vocal tract model of at least one known speaker.
Patent AU-717888-B2 (AU)
Title: Multifocal spectacle lens
Inventor: KELCH GERHARD
IPC: G02C7/02
Filed: 1997-03-25
Granted: 2000-04-06
Abstract: The close reference point is nasally staggered in position at most 21 millimetres vertically under the remote reference point, and preferably by 2.5 millimetres. The close and remote areas are joined by a main vision line forming a curve curving variably towards the nose, in conjunction with remote partial effect and addition. On both sides of the main vision line is an area in the progression zone in which the astigmatic deviation is less than 0.75 dioptre. A minimum width of this area is given in a horizontal direction. Below the horizontal line at whose intersection with the main vision line half the addition is produced, the average effect is greater by the value (dW) than the average effect in the remote reference point.
Patent AU-779039-B2 (AU)
Title: Method and compositions for improving allogeneic hematopoietic cell transplantation
Inventor: WALLER EDMUND K
IPC: C12N5/06
Filed: 1999-11-10
Granted: 2005-01-06
Abstract: Methods of reducing or preventing graft versus host disease in an allogeneic hematopoietic system reconstituting cells transplant recipient comprising administering to the recipient allogeneic hematopoietic system reconstituting cells in which the number of dendritic cells has been effectively reduced, thereby reducing or preventing graft versus host disease, are provided. Also provided are methods of increasing the chance of survival for an allogeneic hematopoietic system reconstituting cells transplant recipient comprising administering to the recipient allogeneic hematopoietic system reconstituting cells in which the number of dendritic cells has been effectively reduced, thereby improving the chance for survival of the recipient. Columns for preparing hematopoietic system reconstituting cells prior to their transplantation are disclosed that provide for the selection of CD34+ cells and the removal of dendritic cell progenitors.
Patent AU-704124-B2 (AU)
Title: Ultraviolet cycling oven for polymerization of contact lenses
Inventor: MARTIN WALLACE ANTHONY
IPC: B29C35/08
Filed: 1995-06-09
Granted: 1999-04-15
Abstract: Disclosed are a method and apparatus for molding contact lenses by curing polymerizable compositions in suitably dimensioned molds using ultraviolet or other polymerization-inducing radiation and heat. The molds are moved along a source of radiation such that the intensity of the radiation to which the composition is exposed rises and falls several times, thereby achieving superior results by balancing the initiation and the propagation of the polymerization.
Patent AU-684932-B2 (AU)
Title: Cells with multiple altered epitopes on a surface antigen for use in transplantation
Inventor: CHAPPEL SCOTT C
IPC: A61K35/407
Filed: 1995-03-30
Granted: 1998-01-08
Abstract: Cells suitable for transplantation which have at least two different epitopes on a surface antigen altered prior to transplantation to inhibit rejection of the cells following transplantation into an allogeneic or xenogeneic recipient are disclosed. These cells are more successfully transplanted than cells which have only a single epitope on the surface antigen altered. Preferably, the antigen on the cell surface which is altered is an MHC class I antigen. Two different epitopes on an MHC class I antigen can be altered by contacting the cell with two molecules, such as antibodies or fragments thereof (e.g., F(ab')2 fragments), which bind to two different epitopes on the antigen. Preferred epitopes on human MHC class I antigens to be altered are epitopes recognized by the monoclonal antibodies W6/32 and PT85. Improved methods for transplantation utilizing cells which have at least two different epitopes on a surface antigen altered prior to transplantation are also disclosed.
Patent AU-753836-B2 (AU)
Title: A method of and a device for acoustically monitoring the course of a process, such as a milking process
Inventor: OORT DICK MARIUS
IPC: G10L15/00
Filed: 1999-04-30
Granted: 2002-10-31
Abstract: The invention relates to a sensor for measuring the amplitude difference and/or the intensity value of sound, said sensor being provided with a piezo-sensor (4), such as a piezoelectric transducer (12),  characterized in that  the sensor (4) comprises a housing (5) which is made of a material having a strongly absorbing capacity for sound and/or vibrations, such as silicones, for example, while at least one piezoelectric sensor (12) is embedded in said housing (5).
Patent AU-620356-B2 (AU)
Title: Ultra high melt flow rate propylene polymers
Inventor: WALKER DALE ANDREW
IPC: C08F10/06
Filed: 1988-11-24
Granted: 1992-02-20
Abstract: An ultra high molecular melt flow rate propylene polymer in which the molecular weight distribution Q is not inversely proportional to the melt flow rate is produced, without post-reactor treatment, by contacting propylene and hydrogen, in the gas phase in the presence of a high activity catalyst.
Patent AU-776786-B2 (AU)
Title: Electro therapy method and apparatus
Inventor: CARTER JOHN
IPC: A61N1/32
Filed: 2001-01-08
Granted: 2004-09-23
Abstract: An apparatus for providing therapeutic electric current to a treatment site of a patient is disclosed, which provides two oscillating or pulsing electric alternating currents, of frequencies which differ from each other by as little as 1 Hz and up to about 250 Hz, but each being of frequency at least about 1 KHz. The apparatus requires only one feed electrode adapted to feed the electric currents to selected feed sites on or beneath the epidermal or mucous surface of the patient, and only one return electrode adapted to be positioned on or beneath the epidermal or mucous surface of the patient, locally to the treatment site. The apparatus includes a feedback subsystem to detect impedance changes in the patient and accordingly adjust the output of the apparatus.
Patent AU-698276-B2 (AU)
Title: Purified polyporus laccases and nucleic acids encoding same
Inventor: YAVER DEBBIE SUE
IPC: C09B53/02
Filed: 1995-06-15
Granted: 1998-10-29
Abstract: The present invention relates to isolated nucleic acid constructs containing a sequence encoding a Polyporus laccase, and the laccase proteins encoded thereby.
Patent AU-716391-B2 (AU)
Title: Solid phase synthesis of oligonucleotides
Inventor: PFLEIDERER WOLFGANG
IPC: C07H19/20
Filed: 1997-07-09
Granted: 2000-02-24
Abstract: Process for the production of oligo:nucleotide(s) by solid phase synthesis comprises: (a) sequential addition of the nucleotides to the solid carrier by known methods, where exocyclic amino groups are protected by cyclic di:acyl groups and any phosphate-protecting groups can be removed by strong, non-nucleophilic base; (b) deprotection of the oligo:nucleotide while it is still bound to the carrier; and (c) splitting of the deprotected oligonucleotide from the solid carrier. Deprotection is carried out using a strong, non-nucleophilic base in organic solvent. Also claimed are compounds of formula (V). R' = P(Z')NR11`R12; R" = H, 1-18C alkoxy, optionally mono- to tri- substituted by OH, or 1-4C alkoxy, 1-4C alkyl-O-(CH2CH2O)s, allyloxy, F, Cl, N3 or protected OH or NH2; A = O, S or CH2; V = O, S or NH; Y = O, S, NH or CH2; Sp = 5-protecting group that can be removed with acid; Bpr = natural or non-natural nucleo-base with exocyclic NH2 groups, where the NH2 groups are protected by a cyclic diacyl group; Z' = OR13, 1-18C alkoxy, 6-20C aryl or 6-14C aryl-(1-8C) alkyl; R11, R12 = 1-8C alkyl (preferably i-Pr) or 5-12C cycloalkyl (preferably 8C), benzyl or phenyl; or NR11R12 = optionally unsaturated heterocyclic ring, optionally with other heteroatoms ( such as morpholine) and substituents (such as OCOO(1-4C)alkyl), and R13 = p-nitrophenylethyl or 2-cyanoethyl.
Patent AU-778994-B2 (AU)
Title: Pharmaceutical preparation and method for treatment of diabetes
Inventor: FREDMAN PAM
IPC: A61K31/715
Filed: 2001-01-29
Granted: 2004-12-23
Abstract: A method for treatment of a diabetic condition, wherein a therapeutically effective amount of at least one isoform of sulfatide is administered to a patient, wherein said at least one isoform of sulfatide upon administration to the patient affects the sulfatide metabolism in such a way that it results in an increased amount of sulfatide. Also the use of at least one isoform of sulfatide for the production of a pharmaceutical preparation for treatment of a diabetic condition is disclosed. Said isoform is preferably an isoform with 8-24 carbon atoms in the fatty acid chain, more preferably 12, 14, 16 or 18 carbon atoms, and most preferably 16 carbon atoms.
Patent AU-764607-B2 (AU)
Title: Organophosphorus compounds for dental polymerizable compositions
Inventor: OKADA KOICHI
IPC: C07F9/40
Filed: 2000-03-30
Granted: 2003-08-28
Abstract: An organic phosphate compound having at least one radically polymerizable double bond, at least one phosphate residue having one or two hydroxyl groups, and at least one hydrocarbon group having 4 or more carbon atoms in a molecule, wherein a 10% by weight methanol solution of the organic phosphate compound has an electric conductivity at 25° C. of 0.5 mS/cm or less, and/or the organic phosphate compound has a light transmittance at 455 nm of 90% or more; a process for preparing the organic phosphate compound; a dental polymerizable composition comprising (a) the organic phosphate compound and (b) a polymerizable monomer capable of copolymerizing with the organic phosphate compound.
Patent AU-693273-B2 (AU)
Title: Fluid change system
Inventor: CLARK JAMES E II
IPC: F16N33/00
Filed: 1995-09-26
Granted: 1998-06-25
Abstract: A fluid change system (10) for use in changing fluid, i.e. motor oil from machinery has a portable "suitcase" unit (12) and a recharge unit (14) for recharging the suitcase unit. The suitcase unit has a used fluid tank (22), a new fluid tank (20), and a compressed air tank (18) and a four way control valve (56). Recharge ports (58, 60, 62, 64, 66) allow for recharge of the suitcase unit through which the new fluid tank is refilled with new fluid and recharged with pressurized inert gas, the used fluid tank is emptied and placed under vacuum, and the compressed air tank is refilled with compressed air. A venturi (84) allows extra vacuum to be placed on the used fluid tank by a user. A computer (212) controls the recharge sequence.
Patent AU-578453-B2 (AU)
Title: Automatic current collector for trolley vehicle
Inventor: LING BERNT
IPC: B60L5/36
Filed: 1985-03-05
Granted: 1988-10-27
Abstract: Electrically powered trolley vehicles in headings of mines are provided with a current collector pick-up unit having contact-sensing means, current collectors, position sensors and guide wheels. The power supply for the pick-up unit comprises an array of elongated guide rails and at least two conductor bars. The connecting method comprises running the vehicle slowly forwards, by means of its own energy source, in the direction of the elongated conductor bars and vertically raising the pick-up unit by means of an arm mounted on the vehicle so that a contact-sensing frame for sensing contact in a vertical direction is brought into engagement with one or both of the guide rails. During a continued vertical movement, the contact-sensing frame is turned down towards the rest of the pick-up unit and when the contact-sensing frame reaches its lower end limit position, this is indicated by a position sensor. The pick-up unit is then turned in the lateral direction until contact-sensing bars for horizontal sensing are brought into engagement with the nearest guide rail. When the position sensors indicate this, the frame is lowered and the pick-up unit with its current collectors and guide wheels is raised towards the conductor array, whereby the current collectors are brought into contact with the conductor bars and the guide wheels are brought into contact with the guide rails.
Patent AU-626155-B2 (AU)
Title: Titanium agglomerates
Inventor: HALL JOHN SYDNEY
IPC: C22B34/12
Filed: 1989-07-25
Granted: 1992-07-23
Abstract: A process for increasing the particle size of fines of a titaniferous mineral containing more than 45 % by weight of titanium. The process comprises mixing the fines with a binding agent and water to produce an agglomerate. The agglomerate is then dried and sintered.
Patent AU-585500-B2 (AU)
Title: Corticotropin releasing factor analogs
Inventor: RIVIER CATHERINE LAURE
IPC: C07K14/00
Filed: 1985-02-21
Granted: 1989-06-22
Abstract: Agonists of rCRF and oCRF are disclosed that can be administered to achieve a substantial elevation of ACTH. ß-endorphin, ß-lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. One agonist which has been found to be particularly potent is: H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH<sub>2</sub>. In the agonists, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and cr by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. Similar peptides which function as CRF antagonists are ceated by deleting the first 7, 8 or 9 N-terminal residues. These analogs or pharmaceuncally or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier can be administered to mammals, including humans The agonists may also be used as stimulants to elevate mood and improve memory and teaming, as well as diagnostically. The antagonists can be used to lower stress.
Patent AU-768853-B2 (AU)
Title: Video compression with storage reduction, color rotation, combined signal and border filtering
Inventor: LYNCH WILLIAM C
IPC: H04N7/30
Filed: 1999-05-14
Granted: 2004-01-08
Abstract: A technique (200) for compressing video images (102) uses temporary compression of blocks during compression, integrated color rotation of compressed images, direct compression of a composite video signal, and border filters to allow blocks to be compressed independently. Temporary compression reduces storage needed in an integrated circuit. An incoming frame (12) is compressed block-by-block and placed in temporary storage (118). A corresponding block of a later frame is also compressed. Both blocks are decoded back into the transform domain and the two blocks are compared in the transform domain (122). Color rotation (132) on compressed color information is integrated with overall compression and is performed upon the chrominance transform pyramids (592, 596) after transformation of the video signal rather than performing a rotation on the raw signal itself. Color rotation (132) is performed at any stage and uses serial multiplication (shift and add) for more efficient processing, rather than using parallel multiplication. A composite video signal (82) including both color and black and white information is compressed directly without separating the color information from the black and white. A sequence of passes (214, 224, Figs. 12-16) separates the luminance and chrominance information from the composite video signal and demodulates the color carrier to separate out color information. Blocks of information are treated independently using a modified 2-6 Biorthogonal filter (106a, 409) to reduce complexity, to reduce harware needed and to reduce blocking artifacts. The technique identifies and compresses composite video, S video, and component video signals, and is applicable to low bit rate video applications.
Patent AU-675432-B2 (AU)
Title: Surface modified anticancer nanoparticles
Inventor: LIVERSIDGE GARY G
IPC: A61P35/00
Filed: 1993-06-29
Granted: 1997-02-06
Abstract: Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the particles exhibit reduced toxicity and/or enhanced efficacy, and can be administered by intravenous injection.